Bio-Techne: stocks, financial statements

Disable ads for free
Dividends News
Favorites

Manufactures and sells biological products

  • TECH Ticker
  • NASDAQ Exchange
  • 1,943 Employees
3 rated
  • $423.05, +$12.07 (+2.94%) Previous Close
  • 216,439 Previous Volume
  • $228.24 / $444.83 52 week low / high
  • -4.90% Percent off 52 week high
  • 2021-05-07 Updated
  • 0.30% Dividend Yield (trailing)
  • 0.30% Dividend Yield (forward)
  • 0 Public float
  • 38,891,663 Outstanding shares
  • 90.80 P/E
  • 15.88 B Market Cap
Disable ads for free

Financial statements — Bio-Techne

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
740M 710M 640M 560M 500M
Cost Of Revenue
260M 240M 210M 190M 160M
Gross Profit
480M 470M 430M 370M 340M
Research and Development
65M 62M 55M 54M 45M
Selling General and Admin
260M 260M 240M 200M 140M
Operating Expense
580M 570M 510M 440M 350M
Operating Income
160M 150M 140M 120M 150M
Other Income Expense Net
0 0 0 0 0
EBIT
160M 150M 140M 120M 150M
Interest Income
19M 21M 9.8M 7.1M 1.5M
Pretax Income
280M 110M 130M 110M 150M
Income Tax
47M 16M -200K 36M 43M
Minority Interest
0 0 0 0 0
Net Income
230M 96M 130M 76M 100M
Net Income Basic
230M 96M 130M 76M 100M
20 ← 16 2020 2019 2018 2017 2016
Current cash
270M 170M 180M 160M 96M
Short term investments
24M 18M 11M 13M 7.6M
Receivables
120M 140M 120M 120M 93M
Inventory
100M 91M 86M 60M 57M
Other current assets
24M 18M 11M 13M 7.6M
Current assets
520M 410M 400M 350M 250M
Long term investments
1.5B 1.5B 1.2B 1.2B 880M
Property plant equipment
180M 150M 150M 140M 130M
Goodwill
730M 730M 600M 580M 430M
Intangible assets
520M 580M 450M 450M 310M
Other assets
14M 5.7M 2.7M 3.6M 1.9M
Total assets
2B 1.9B 1.6B 1.6B 1.1B
Accounts payable
23M 16M 18M 17M 21M
Current long term debt
13M 13M 0 0 3.8M
Other current liabilities
71M 73M 61M 120M 30M
Total current liabilities
110M 100M 80M 140M 54M
Long term debt
340M 490M 340M 340M 92M
Other liabilities
27M 34M 9.3M 8.7M 42M
Minority Interest
0 0 0 0 0
Total Liabilities
650M 720M 510M 610M 250M
Common stock
38M 38M 37M 37M 37M
Retained earning
1.1B 930M 880M 800M 770M
Treasury stock
0 0 0 0 0
Capital surplus
Shareholder equity
1.4B 1.2B 1.1B 950M 880M
Net tangible assets
140M -150M 35M -81M 140M
20 ← 16 2020 2019 2018 2017 2016
Net Income
230M 96M 130M 76M 100M
Depreciation
83M 78M 64M 60M 43M
Changes in receivables
-15M 17M 3.5M 23M 23M
Changes in inventories
12M 5.4M 25M 3M 7.5M
Cash change
100M -16M 24M 62M -15M
Cash flow
210M 180M 170M 140M 140M
Capital expenditures
-52M -25M -21M -15M -17M
Investments
Investing activity other
Total investing cash flows
27M -340M -39M -310M -110M
Dividends paid
Net borrowings
62M 320M 150M 170M -8.1M
Other financing cash flows
Cash flow financing
-180M 130M -99M 190M -23M
Exchange rate effect
Disable ads for free
Disable ads for free